You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨啟明醫療-B(2500.HK)反彈逾5% 獲券商看高目標價至105港元
格隆匯 07-28 10:58
格隆匯7月28日丨此前連續大跌的啟明醫療-B(2500.HK)今日反彈逾5%,報47.45港元,暫成交5624萬港元,總市值210億港元。華創證券日前表示,維持啟明醫療-B“推薦”評級,目標價105港元,較目前價位有翻倍空間。該行指,今年上半年,公司TAVR手術終端植入量約為1900台(包含部分捐贈性質植入),較去年同期約700台終端植入量增長迅速。腦保護器裝置Tri GUARD3海外收入亦大幅提升。另外,公司委任Martin B. Leon教授擔任RDN創新器械全球首要研究者,在RDN領域,Martin教授及其團隊已擔任多個創新器械的臨牀試驗PI。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account